• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

A Decade in the Anti-Obesity Arena

Commentary
Podcast

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

In this episode of the Pharmaceutical Executive Podcast, Currax Pharmaceuticals CEO, George Hampton discusses:

  • Contrave
  • What patient success has looked like
  • How different kinds of therapies perform and fit in the current business landscape
  • Ethical and regulatory problems for weight loss companies like WW, Noom, and Ro present
  • How can access to these weight loss drugs help the obesity epidemic
  • and much more!
Recent Videos
Related Content
Our Top 5 Podcast Episodes of 2023

Our Top 5 Podcast Episodes of 2023

December 27th 2023
Article

Our top five episodes of the year.

A Different Approach to Dermatology Care

A Different Approach to Dermatology Care

Miranda Schmalfuhs
September 23rd 2024
Podcast

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.

Site Logo

Episode 67: Succeeding Through Adversity

Elaine Quilici
October 15th 2020
Article

Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance clinical trials for its lead cancer drug through COVID-19.

Beyond the Birthrate: The Societal Costs of Maternal Mortality

Beyond the Birthrate: The Societal Costs of Maternal Mortality

Miranda Schmalfuhs
September 6th 2024
Podcast

Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.

Site Logo

Episode 60: Leading With Compassion

Elaine Quilici
July 9th 2020
Article

Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing a company through COVID-19, in light of the fact that he himself is immunocompromised.

Site Logo

Episode 59: Using Tau to Target Alzheimer’s

Christen Harm;Elaine Quilici
June 25th 2020
Article

Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.